CCG News and Events
CCG in the News
September 27-29, 2018 in Washington, DC, USA
A meeting highlighting TCGA's legacy to the field and looking at the future of multi-omics studies in cancer. The symposia will feature the latest advances on the genomic underpinnings of cancer, discuss the ongoing revolution in cancer classification, and showcase recent progress toward therapeutic targeting.
Submit your abstract by June 15, 2018
NCI Center for Cancer Genomics (CCG) research initiatives have been widely recognized in the news media for their goals of facilitating advances in cancer genomic research and improving patient diagnosis and treatment. Below are selected articles describing CCG research.
NCI Genomic Data Commons experts: Toward a Shared Vision for Cancer Genomic Data
The New England Journal of Medicine | September 28, 2016
The Information Cure: Big data is about to revolutionize the way we combat cancer
Chicago Magazine | December 15, 2016
Cancer researchers: It's time to pay more attention to 'miracle' patients
The Washington Post | August 26, 2016
The Human Genome Is Having Its Facebook Moment
Chicago Magazine | August 9, 2016
Global initiative seeks 1,000 new cancer models
Nature | July 11, 2016
Major funders launch international repository of cutting-edge cancer models
Science Magazine | July 11, 2016
The Rock Fuel for Biden's "Cancer Moonshot"? Big Data
MIT Technology Review | June 29, 2016
Biden unveils launch of major, open-access database to advance cancer research
The Washington Post | June 6, 2016
NCI's Staudt and Kibbe: Data Commons Will Publish Annotated Raw Genomic Data
The Cancer Letter | April 29, 2016
The Cancer Genome Atlas (TCGA) has been a landmark effort to generate comprehensive, multidimensional maps of genomic changes on over 11,000 cancer cases from 33 different cancer types. These symposia will peer into the future of multi-omics studies in cancer, and highlight TCGA’s legacy to the field. The meeting will feature the latest advances on the genomic underpinnings of cancer, discuss the ongoing revolution in cancer classification, and showcase recent progress toward therapeutic targeting. Our aim is to bring together participants from both within and outside of the TCGA Network to stimulate exciting discussions, foster collaborations, and accelerate the translation of basic research discoveries to new cancer treatments.
Come visit the Genomic Data Commons (GDC) at the ASCO 2018 Annual Meeting at McCormick Place in Chicago, IL. GDC experts will be available to help you explore the website and tools, answer questions, and take your feedback.
June 3 & 4
9AM – 5PM
NCI Exhibit Booth #5041
Meet the Experts session: Exploring and Visualizing Data in the NCI Genomic Data Commons
Sunday, June 3
10 - 10:30AM
Presented by Michael Fitzsimons, Ph.D.
GDC User Services Manage
IDG has published a new funding opportunity, Cutting Edge Informatics Tools for Illuminating the Druggable Genome, which focuses on the development of new cutting edge informatics tools (CEITs) to support the IDG program. IDG will be hosting a Pre-Application Webinar on May 31, 2018 from 11:00 AM - 1:00 PM EST.
The Genomic Data Commons (GDC) has launched DAVE: Data Analysis, Visualization, and Exploration Tools. The online interface, equipped with plots and visualizations, allows any researcher to easily explore genomic and clinical data for over 14K cancer patients--without any bioinformatics expertise.
Visit the Genomic Data Commons (GDC) kiosk at the American Society of Clinical Oncology (ASCO) 2017 Annual Meeting in Chicago, Illinois, to learn more about the GDC's data and tools or to engage GDC experts in one-on-one discussion.
June 3 - 5, 9:00 AM – 5:00 PM CT, NCI Exhibit Booth #4052, McCormick Place, Chicago, Illinois.
Preview new GDC tools at a Meet the Experts session: The Genomic Data Commons: Demo of New Data Analysis, Visualization, and Exploration (DAVE) Tools, presented by GDC User Services Manager Michael Fitzsimmons, Ph.D.
June 4, 10:15 AM CT, NCI Exhibit Booth #4052, McCormick Place, Chicago, Illinois.
Genomic Data Commons Co-Principal Investigator Robert Grossman, Ph.D., and NCI's representatives for the Cancer Genomics Cloud Pilots, Tanja Davidsen, Ph.D., and Anthony Kerlavage, Ph.D., discussed recent advances in health data-sharing technology in the session NCI's Genomic Data Commons and ASCO's CancerLinQ at Health Datapalooza in Washington, DC.
Friday, April 28, 8:45 AM - 10:00 AM EST.
CCG was featured in three sessions at the 2017 American Association for Cancer Research (AACR) Annual Meeting in Washington, DC, and CCG representatives were available to answer questions at the NCI Exhibit Booth #1407:
- Genomic Data Commons Live Demonstration, Meet the Experts Session with GDC User Services Manager Michael Fitzsimmons, Ph.D.
- Genomic Data Commons Question & Answer with NCI Project Officer for the GDC Zhining Wang, Ph.D.
- NCI's Center for Cancer Genomics and Cloud Pilots Initiatives: Using Large-Scale Data to Advance Precision Oncology
This workshop, held on Thursday, February 2, 2017, from 12 to 1 PM EST, introduced users to the GDC tools for downloading and retrieving data from cancer genomic studies. It also reviewed the process for obtaining access to controlled data and answered user questions.
Navigating the GDC - A Case Study, held November 17th at noon EST, was the first web conference workshop in a series of NCI GDC Workshops. This workshop introduced users to GDC tools and data types and demonstrated how to perform examples of common genomic analyses using the GDC.
As a part of the DNA Day Series hosted by the National Human Genome Research Institute, Dr. Jean Claude Zenklusen, Director of The Cancer Genome Atlas (TCGA), participated in the New Reddit Journal of Science Ask me Anything (AMA) Series on Friday, April 22, 2016. Anonymous participants posted questions on the Reddit AMA page about cancer, genomics research, training in science, TCGA, and many other topics. Dr. Zenklusen answered 77 questions from Reddit participants, and the page received 2,400 "upvotes" by Reddit users.
CCG was featured in seven sessions at the American Association for Cancer Research (AACR) Annual Meeting in New Orleans, Louisiana.